Fenglan Zhang

Featured in: Favicon

nature.com Favicon

dovepress.com Favicon

onlinelibrary.wiley.com

Articles

Zn/Cu Bi‐Single‐Atom Nanoplatform: Hexagonal Anti‐Tumor Warrior by ROS Amplification for DOX Resistance Reversal and Immune Activation

Sep 30, 2024 | onlinelibrary.wiley.com | Tianyi Wang |Fenglan Zhang |Carlos F. Guimarães |Rui L Reis

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202410962-sup-0001-SuppMat.docx27.9 MB Supporting Information References 1, , , , , , , , , , , Adv. Sci. 2024, 11, 2309917. 2, , , , , , , , , , , , , , , , , , , , , , , Nat. Biotechnol. 2024, 36, 1. 3, , , , , , , , J. Controlled Release 2021, 332, 10. 4, , , , , , , , , , , , , Nat. Commun. 2016, 7, 12225.
Zn/Cu Bi‐Single‐Atom Nanoplatform: Hexagonal Anti‐Tumor Warrior by ROS Amplification for DOX Resistance Reversal and Immune Activation

Sep 30, 2024 | pericles.pericles-prod.literatumonline.com | Tianyi Wang |Fenglan Zhang |Carlos F. Guimarães |Rui L Reis

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202410962-sup-0001-SuppMat.docx27.9 MB Supporting Information References 1, , , , , , , , , , , Adv. Sci. 2024, 11, 2309917. 2, , , , , , , , , , , , , , , , , , , , , , , Nat. Biotechnol. 2024, 36, 1. 3, , , , , , , , J. Controlled Release 2021, 332, 10. 4, , , , , , , , , , , , , Nat. Commun. 2016, 7, 12225.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →